Liquidia Corporation (LQDA) Stock Ticker
LQDA right now
Market factors today
Unlock the full LQDA picture
About Liquidia Corporation
Liquidia Corporation operates as a biopharmaceutical enterprise, concentrating on the development, production, and market introduction of various treatments aimed at fulfilling critical patient requirements throughout the United States. A key asset in its developmental portfolio is YUTREPIA, an innovative inhaled dry powder version of treprostinil, intended for managing pulmonary arterial hypertension. Beyond its pipeline, the company also distributes a generic treprostinil injection within the U.S. market. Founded in 2004, Liquidia Corporation's main office is located in Morrisville, North Carolina.
LQDA stock facts
| Ticker symbol | LQDA |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Medical - Pharmaceuticals |
| Market cap | $6.1B |
| CEO | Roger A. Jeffs |
| Employees | 216 |
| Headquarters | Morrisville, NC, US |
| IPO date | 2018-07-26 |
| Website | www.liquidia.com |
What you can see for LQDA on Tickr
Live LQDA price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the LQDA report.
Rankings
LQDA peers
FAQ
What is the ticker symbol for Liquidia Corporation?
The ticker symbol for Liquidia Corporation is LQDA, listed on the NASDAQ Capital Market.
What is LQDA?
Liquidia Corporation operates as a biopharmaceutical enterprise, concentrating on the development, production, and market introduction of various treatments aimed at fulfilling critical patient requirements throughout the United States. A key asset in its developmental portfolio is YUTREPIA, an innovative inhaled dry powder version of treprostinil, intended for managing pulmonary arterial…